Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG

AIDS Research and Therapy

Volumn 9, Issue , 2012, Pages

  Hartjen, Philip ^a,b   Frerk, Sebastian ^a,b   Hauber, Ilona ^b   Matzat, Verena ^a,b   Thomssen, Adriana ^a,b   Holstermann, Barbara ^b   Hohenberg, Heinrich ^b   Schulze, Wolfgang ^a   Schulze zur Wiesch, Julian ^a,b   van Lunzen, Jan ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

EGCG; HIV transmission; Microbicide; Semen; SEVI

Indexed keywords

EPIGALLOCATECHIN GALLATE; SEMEN DERIVED ENHANCER OF VIRUS INFECTION; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MALE; NONHUMAN; PRIORITY JOURNAL; SPERM; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INFECTIVITY; VIRUS INHIBITION;

EID: 84855887142     PISSN: None     EISSN: 17426405     Source Type: Journal    
DOI: 10.1186/1742-6405-9-2     Document Type: Article

References (32)

1. UNAIDS UNAIDS annual report 2009. UNAIDS.
2. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol 2005, 5:783-792. 10.1038/nri1706, 16200081.
3. Gupta K, Klasse PJ. How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?. PLoS Med 2006, 3:e79. 10.1371/journal.pmed.0030079, 1388058, 16492075.
4. Sabatte J, Lenicov FR, Cabrini M, Rodriguez CR, Ostrowski M, Ceballos A, Amigorena S, Geffner J. The role of semen in sexual transmission of HIV: beyond a carrier for virus particles. Microbes Infect 2011, 13:977-982. 10.1016/j.micinf.2011.06.005, 21767659.
5. Münch J, Rücker E, Ständker L, Adermann K, Goffinet C, Schindler M, Wildum S, Chinnadurai R, Rajan D, Specht A, et al. Semen-derived amyloid fibrils drastically enhance HIV infection. Cell 2007, 131:1059-1071. 10.1016/j.cell.2007.10.014, 18083097.
6. Roan NR, Greene WC. A seminal finding for understanding HIV transmission. Cell 2007, 131:1044-1046. 10.1016/j.cell.2007.11.030, 18083095.
7. Hauber I, Hohenberg H, Holstermann B, Hunstein W, Hauber J. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection. Proc Natl Acad Sci USA 2009, 106:9033-9038. 10.1073/pnas.0811827106, 2683882, 19451623.
8. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany ABM, Sibeko S, Mlisana KP, Omar Z, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010, 329:1168-1174. 10.1126/science.1193748, 3001187, 20643915.
9. Wang L, Schnaare RL, Dezzutti C, Anton PA, Rohan LC. Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulations. AIDS Res Ther 2011, 8:12. 10.1186/1742-6405-8-12, 3061893, 21385339.
10. World Health Organization WHO Laboratory Manual for the examination of human semen and sperm-cervical mucus interaction 1999, Cambridge University Press, 4, World Health Organization.
11. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A, Wanker EE. EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat Struct Mol Biol 2008, 15:558-566. 10.1038/nsmb.1437, 18511942.
12. Kim K-A, Yolamanova M, Zirafi O, Roan NR, Staendker L, Forssmann W-G, Burgener A, Dejucq-Rainsford N, Hahn BH, Shaw GM, et al. Semen-mediated enhancement of HIV infection is donor-dependent and correlates with the levels of SEVI. Retrovirology 2010, 7:55. 10.1186/1742-4690-7-55, 2914040, 20573198.
13. Wurm M, Schambach A, Lindemann D, Hanenberg H, Standker L, Forssmann WG, Blasczyk R, Horn PA. The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J Gene Med 2010, 12:137-146.
14. Martellini JA, Cole AL, Venkataraman N, Quinn GA, Svoboda P, Gangrade BK, Pohl J, Sorensen OE, Cole AM. Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma. FASEB J 2009, 23:3609-3618. 10.1096/fj.09-131961, 3236594, 19487309.
15. Martellini JA, Cole AL, Svoboda P, Stuchlik O, Chen LM, Chai KX, Gangrade BK, Sorensen OE, Pohl J, Cole AM. HIV-1 enhancing effect of prostatic acid phosphatase peptides is reduced in human seminal plasma. PLoS One 2011, 6:e16285. 10.1371/journal.pone.0016285, 3024420, 21283773.
16. Malm J, Hellman J, Hogg P, Lilja H. Enzymatic action of prostate-specific antigen (PSA or hK3): substrate specificity and regulation by Zn(2+), a tight-binding inhibitor. Prostate 2000, 45:132-139. 10.1002/1097-0045(20001001)45:2<132::AID-PROS7>3.0.CO;2-3, 11027412.
17. Kawai K, Tsuno NH, Kitayama J, Okaji Y, Yazawa K, Asakage M, Hori N, Watanabe T, Takahashi K, Nagawa H. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J Allergy Clin Immunol 2003, 112:951-957. 10.1016/S0091-6749(03)02007-4, 14610487.
18. Liu S, Lu H, Zhao Q, He Y, Niu J, Debnath AK, Wu S, Jiang S. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41. Biochim Biophys Acta 2005, 1723:270-281. 10.1016/j.bbagen.2005.02.012, 15823507.
19. Nance CL, Siwak EB, Shearer WT. Preclinical development of the green tea catechin, epigallocatechin gallate, as an HIV-1 therapy. J Allergy Clin Immunol 2009, 123:459-465. 10.1016/j.jaci.2008.12.024, 2665796, 19203663.
20. Williamson MP, McCormick TG, Nance CL, Shearer WT. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy. J Allergy Clin Immunol 2006, 118:1369-1374. 10.1016/j.jaci.2006.08.016, 17157668.
21. Isaacs CE, Wen GY, Xu W, Jia JH, Rohan L, Corbo C, Di Maggio V, Jenkins EC, Hillier S. Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus. Antimicrob Agents Chemother 2008, 52:962-970. 10.1128/AAC.00825-07, 2258520, 18195068.
22. Ciesek S, von Hahn T, Colpitts CC, Schang LM, Friesland M, Steinmann J, Manns MP, Ott M, Wedemeyer H, Meuleman P, et al. The green tea polyphenol epigallocatechin-3-gallate (EGCG) inhibits hepatitis C virus (HCV) entry. Hepatology 2011,
23. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 2006, 66:1234-1240. 10.1158/0008-5472.CAN-05-1145, 16424063.
24. Chow H-HS, Cai Y, Hakim IA, Crowell JA, Shahi F, Brooks CA, Dorr RT, Hara Y, Alberts DS. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res 2003, 9:3312-3319.
25. Chow HH, Cai Y, Alberts DS, Hakim I, Dorr R, Shahi F, Crowell JA, Yang CS, Hara Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev 2001, 10:53-58.
26. Ullmann U, Haller J, Decourt JP, Girault N, Girault J, Richard-Caudron AS, Pineau B, Weber P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J Int Med Res 2003, 31:88-101.
27. Stratton SP, Bangert JL, Alberts DS, Dorr RT. Dermal toxicity of topical (-)epigallocatechin-3-gallate in BALB/c and SKH1 mice. Cancer Lett 2000, 158:47-52. 10.1016/S0304-3835(00)00498-5, 10940508.
28. Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC. Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002, 46:1896-1905. 10.1128/AAC.46.6.1896-1905.2002, 127242, 12019106.
29. Platt EJ, Wehrly K, Kuhmann SE, Chesebro B, Kabat D. Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J Virol 1998, 72:2855-2864. 109730, 9525605.
30. Gartner S, Markovits P, Markovitz DM, Kaplan MH, Gallo RC, Popovic M. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 1986, 233:215-219. 10.1126/science.3014648, 3014648.
31. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59:284-291. 253077, 3016298.
32. Hohenberg H, Mannweiler K, Muller M. High-pressure freezing of cell suspensions in cellulose capillary tubes. J Microsc 1994, 175:34-43. 10.1111/j.1365-2818.1994.tb04785.x, 7932676.